Horseracing Integrity and Safety Act of 2020
- Last Action
- 9/30/2020
Actions
- 2020-09-30Received in the Senate.
- 2020-09-29Motion to reconsider laid on the table Agreed to without objection.
- 2020-09-29On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4973-4980)
- 2020-09-29Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
- 2020-09-29Placed on the Union Calendar, Calendar No. 454.
- 2020-09-29Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-554.
- 2020-09-29Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-554.
- 2020-09-29DEBATE - The House proceeded with forty minutes of debate on H.R. 1754.
- 2020-09-29Considered under suspension of the rules. (consideration: CR H4973-4983)
- 2020-09-29Mr. Pallone moved to suspend the rules and pass the bill, as amended.
- 2020-09-09Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 5.
- 2020-09-09Committee Consideration and Mark-up Session Held.
- 2019-03-15Referred to the Subcommittee on Consumer Protection and Commerce.
- 2019-03-14Referred to the House Committee on Energy and Commerce.
- 2019-03-14Introduced in House
Showing 15 of 16 actions. Full history on Congress.gov.
CRS Summary
As of 2020-09-29 (53)
Horseracing Integrity and Safety Act of 2020
This bill recognizes the Horseracing Integrity and Safety Authority for purposes of developing and implementing a horseracing anti-doping and medication control program and a racetrack safety program.
The authority shall establish an anti-doping and medication control standing committee and a racetrack safety standing committee to provide guidance to the authority on the development and maintenance of the programs.
The Federal Trade Commission (FTC) shall have oversight over the authority. The authority shall submit to the FTC any proposed rule, standard, or procedure developed by the authority to carry out the horseracing anti-doping and medication control program or the racetrack safety program. The authority shall seek to enter into an agreement with the U.S. Anti-Doping Agency or an entity equal in qualification under which the entity acts as the anti-doping and medication control enforcement agency under this bill.
Among the required elements of the horseracing safety program are sets of training and racing safety standards consistent with the humane treatment of horses, a system to maintain track surface quality, programs for injury and fatality analysis, investigation and disciplinary procedures, and an evaluation and accreditation program.
The bill sets forth other provisions regarding (1) funding, conflicts of interest, and jurisdiction; (2) registration with the authority; (3) program enforcement; (4) rule violations and civil sanctions; (5) testing laboratories; (6) review of final decisions of the authority by an administrative law judge; (7) unfair or deceptive acts or practices; and (8) agreements with state racing commissions.
Cosponsors (20)
- Andy Barr (R-KY)
- Dina Titus (D-NV)
- JANICE SCHAKOWSKY (D-IL)
- EARL BLUMENAUER (D-OR)
- Tony Cárdenas (D-CA)
- Kathy Castor (D-FL)
- Derek Kilmer (D-WA)
- Sean Maloney (D-NY)
- Thomas Suozzi (D-NY)
- ADAM SCHIFF (D-CA)
- Steve Cohen (D-TN)
- GREGORY MEEKS (D-NY)
- ROSA DELAURO (D-CT)
- Kathleen Rice (D-NY)
- Chris Collins (R-NY)
- Tulsi Gabbard (D-HI)
- Raja Krishnamoorthi (D-IL)
- Rodney Davis (R-IL)
- Steve Watkins (R-KS)
- Jackie Walorski (R-IN)
Subjects
- Administrative law and regulatory procedures
- Administrative remedies
- Advisory bodies
- Animal protection and human-animal relationships
- Athletes
- Business ethics
- Civil actions and liability
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Federal Trade Commission (FTC)
- Fraud offenses and financial crimes
- Gambling
- Government studies and investigations
- Health information and medical records
- Intergovernmental relations
- Mammals
- Medical ethics
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.